Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis (Q47589093)

4 February 2018

title

Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis (English)

1 reference

4 February 2018

1

Alois Gratwohl

1 reference

4 February 2018

Dietger Niederwieser

12

object named as

Dietger Niederwieser

1 reference

4 February 2018

author name string

Martin Stern

2

1 reference

4 February 2018

Ronald Brand

3

1 reference

4 February 2018

Jane Apperley

4

1 reference

4 February 2018

Helen Baldomero

5

1 reference

4 February 2018

Theo de Witte

6

1 reference

4 February 2018

Giorgio Dini

7

1 reference

4 February 2018

Vanderson Rocha

8

1 reference

4 February 2018

Jakob Passweg

9

1 reference

4 February 2018

Anna Sureda

10

1 reference

4 February 2018

André Tichelli

11

1 reference

4 February 2018

European Group for Blood and Marrow Transplantation and the European Leukemia Net

13

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 October 2009

1 reference

4 February 2018

published in

Cancer

1 reference

4 February 2018

volume

115

1 reference

4 February 2018

issue

20

1 reference

4 February 2018

page(s)

4715-4726

1 reference

4 February 2018

Hematopoietic-cell transplantation at 50.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Lifetime probabilities of hematopoietic stem cell transplantation in the U.S

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Age and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Acute promyelocytic leukemia: from highly fatal to highly curable

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

CMV infections after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Time-dependent covariates in the Cox proportional-hazards regression model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Regression modelling strategies for improved prognostic prediction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Risk assessment in haematopoietic stem cell transplantation: histocompatibility

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Haematopoietic stem cell transplantation: can our genes predict clinical outcome?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Role of primacy of birth in HLA-identical sibling transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24531

7 January 2021

Identifiers

DOI

10.1002/CNCR.24531

1 reference

4 February 2018

PubMed ID

19642176

1 reference

4 February 2018